Wednesday, June 10, 2026

Drug profile · INN

aciclovir

aciclovir (XOROX) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Apotex Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — aciclovir

Quick answer

aciclovir (XOROX) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Apotex Pty Ltd.

Key facts

INN aciclovir
Brand XOROX
Mechanism Human herpesvirus 1 DNA polymerase inhibitor
Target DNA polymerase catalytic subunit
Originator Apotex Pty Ltd

Mechanism of action

Human herpesvirus 1 DNA polymerase inhibitor

Primary target: DNA polymerase catalytic subunit

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. APHP180592 Phase 3 · PARItec · Diseases [C] - Virus Diseases [C02]
  2. APHP220800 Phase 3 · PARItec · Patients in ICU with invasive mechanical ventilation and HSV
  3. ALL3024 Phase 2 · Telethon Foundation · Very High-Risk T-Lineage Acute Lymphoblastic Leukemia (ALL)
  4. Valaciclovir/Aciclovir Phase 2 · United Therapeutics Europe · Critical Illness

Related & competitor drugs

  1. acyclovir Human herpesvirus 1 DNA polymerase inhibitor
  2. acyclovir sodium Human herpesvirus 1 DNA polymerase inhibitor
  3. famciclovir Human herpesvirus 1 DNA polymerase inhibitor
  4. foscarnet sodium Human herpesvirus 1 DNA polymerase inhibitor
  5. ganciclovir sodium Human herpesvirus 1 DNA polymerase inhibitor
  6. penciclovir Human herpesvirus 1 DNA polymerase inhibitor

Frequently asked questions

What is aciclovir?

aciclovir (XOROX) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Apotex Pty Ltd.

What is the brand name for aciclovir?

XOROX is a marketed brand name for aciclovir. Check FDA Drugs@FDA for the current US label holder and prescribing information.